On Dec 14, Trial Site News published my investigative report on a 38-page Pfizer document, entitled, “Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) receive…
Substack is the home for great culture
On Dec 14, Trial Site News published my investigative report on a 38-page Pfizer document, entitled, “Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) receive…